Simple jQuery Dropdowns
Please use this identifier to cite or link to this item:
Title: Serum tissue polypeptide specific antigen (TPS) in patients with cervical carcinoma : Preliminary report
Authors: Pittayapoom Pattaranutaporn
Yaowalak Chansilpa
Saipin Tangkarat
Pairat Tepmongkol
Supatra Sangruchi
Samrit Senapad
Faculty of Medicine, Thammasat University
National Cancer Institute Thailand
Faculty of Medicine, Siriraj Hospital, Mahidol University
Keywords: Biochemistry, Genetics and Molecular Biology;Medicine
Issue Date: 13-Aug-1997
Citation: Anticancer Research. Vol.17, No.3 C (1997), 2309-2312
Abstract: Tissue polypeptide specific antigen (TPS) was measured by TPS ELISA in the sera of 88 patients with FIGO stage II and III cervical cancer and 93 healthy Thai women as the control group. The mean serum TPS levels were 63.1 U/L in the control group, and 166.4 and 363.2 U/L in stage II and III cervical cancer respectively. The mean of the control group and stage II patients were not significantly different while the mean of stage III patients was significantly different from those two groups (p < 0.0005). With the cut-off value of 90 U/L, the rates of TPS elevation were 22/35 (65.7%) in stage II and 42/53 (79.2%) in stage III patients. As for the pathology, squamous cell carcinoma showed a statistical difference from adenocarcinoma and adenosquamous carcinoma of P = 0.001. For squamous cell carcinoma, there was no difference between the keratinized and non-keratinized type (P = 0.451). TPS is not sensitive in stage II. However, it might be useful for predicting prognosis if the elevation is significantly high, and distant metastases or local recurrence should be investigated.
ISSN: 02507005
Appears in Collections:Scopus 1991-2000

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.